GSK part­ners with Rgen­ta on RNA-tar­get­ed small mol­e­cules for on­col­o­gy, oth­er ar­eas

GSK will team up with Boston-area biotech Rgen­ta Ther­a­peu­tics to cre­ate oral small mol­e­cules that tar­get RNA, the com­pa­nies said Wednes­day morn­ing.

The duo will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER